Regenerative Medicine Utrecht

News

Cell therapy facility fulfills all GMP requirements

Three inspectors from the Healthcare and Youth Inspectorate (IGJ) visited the cell therapy facility (CTF), which is part of the pharmacy, for a GMP inspection (Good Manufacturing Practice). The IGJ regularly checks whether organizations meet the GMP guidelines for producing advanced therapy medicines (ATMPs). They concluded that our CTF works according to these guidelines and…

Read more

Kerstin Schneeberger receives research grant from the Jubileumfonds

Dr. Kerstin Schneeberger received €20,462 from the foundation for Alternatives for Animal Experiments (Bevordering Alternativen Dierproeven fonds), a sub-foundation of the Jubileumfonds. Within the liver group, Kerstin and her colleagues recently developed a novel hydrogel as a replacement for Matrigel. Matrigel is prepared from a basement membrane-rich sarcoma, which must be propagated in mice. Since…

Read more

Support Kerstin Schneeberger for the VIVA400 award!

Kerstin Schneeberger, postdoc in the RMU liver group, has been nominated for the VIVA400 award 2019 for her research on liver tissue engineering. If you would like to support her, you can vote for Kerstin at https://www.viva.nl/viva400/zorgdragers/ by clicking on her name and then on “stem nu”. Afterwards, you will have to verify your email…

Read more

BRAVƎ – Engineering a biological device to support a sick heart

Clinica Universidad de Navarra in Spain leads BRAVƎ, an international research project aimed at restoring cardiac functionality by regenerating cardiac tissue. It is a coordinated project financed by the Horizon 2020 Program from the European Commission with €8M! RMU is one of 13 partners in this consortium. Ischemic cardiomyopathy is one of the most prevalent…

Read more